GEFITINIB ALVOGEN 250 mg România - română - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

gefitinib alvogen 250 mg

pharmadox healthcare ltd. - malta - gefitinibum - compr. film. - 250mg - alte antineoplazice inhibitori de protein-kinaza

GEFITINIB LABORMED 250 mg România - română - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

gefitinib labormed 250 mg

pharmadox healthcare ltd. - malta - gefitinibum - compr. film. - 250mg - inhibitori de protein-kinaza inhibitori ai tirozin kinazei (egfr)

Zoledronic acid Teva Pharma Uniunea Europeană - română - EMA (European Medicines Agency)

zoledronic acid teva pharma

teva b.v. - acid zoledronic - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - medicamente pentru tratamentul bolilor osoase - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. tratamentul de boala paget osoase la adulți.

Dasatinib Accordpharma Uniunea Europeană - română - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - agenți antineoplazici - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

ABACAVIR/LAMIVUDINA GLENMARK 600 mg/300 mg România - română - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

abacavir/lamivudina glenmark 600 mg/300 mg

pharmadox healthcare ltd - malta - abacavirum+lamivudinum - compr. film. - 600mg/300mg - antivirale cu actiune directa antivirale pentru tratamentul infectiei cu hiv, combinatii